source
- China moves to ban export of select biotech platforms while keeping drug licensing openChinese Ministry of Commerce announced it is pursuing an export ban on certain biotechnology platforms. The measure is intended to restrict the types of deals domestic companies can make abroad, r…
- FDA reviews interim access policy for compounded peptides as Enspryng label expandsThe U.S. Department of Health and Human Services and the Food and Drug Administration have drafted a new interim access policy that would allow compounding pharmacies to use certain peptide drugs u…